Which has preferable valuation and earnings, YB or SPNT?

SiriusPoint has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than SiriusPoint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Yuanbao $625.35M 1.13 $181.88M $4.14 3.78 SiriusPoint $3.21B 0.86 $459.60M $4.02 5.83

Is YB or SPNT more profitable?

Yuanbao has a net margin of 29.67% compared to SiriusPoint's net margin of 15.38%. Yuanbao's return on equity of 44.37% beat SiriusPoint's return on equity. Company Net Margins Return on Equity Return on Assets Yuanbao 29.67% 44.37% 30.82% SiriusPoint 15.38% 16.92% 2.88%

Does the media prefer CLOV or YB?

In the previous week, Yuanbao had 1 more articles in the media than Clover Health Investments. MarketBeat recorded 8 mentions for Yuanbao and 7 mentions for Clover Health Investments. Yuanbao's average media sentiment score of 1.02 beat Clover Health Investments' score of 0.52 indicating that Yuanbao is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Yuanbao 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, YB or FIHL?

Fidelis Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Yuanbao $625.35M 1.13 $181.88M $4.14 3.78 Fidelis Insurance $2.17B 1.05 $225.50M $2.21 10.70

Does the media favor YB or FIHL?

In the previous week, Yuanbao had 7 more articles in the media than Fidelis Insurance. MarketBeat recorded 8 mentions for Yuanbao and 1 mentions for Fidelis Insurance. Yuanbao's average media sentiment score of 1.02 beat Fidelis Insurance's score of -0.85 indicating that Yuanbao is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Yuanbao 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fidelis Insurance 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Negative

Which has higher valuation & earnings, PLGO or YB?

Fidelis Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fidelis Insurance $2.50B 0.82 $225.50M $3.74 6.33 Yuanbao $625.35M 1.13 $181.88M $4.14 3.78

Does the media prefer PLGO or YB?

In the previous week, Yuanbao had 7 more articles in the media than Fidelis Insurance. MarketBeat recorded 8 mentions for Yuanbao and 1 mentions for Fidelis Insurance. Yuanbao's average media sentiment score of 1.02 beat Fidelis Insurance's score of 0.75 indicating that Yuanbao is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fidelis Insurance 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Yuanbao 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, SLDE or YB?

Slide Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Slide Insurance, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Slide Insurance $1.16B 1.66 $443.96M $3.60 4.64 Yuanbao $625.35M 1.13 $181.88M $4.14 3.78

Is SLDE or YB more profitable?

Slide Insurance has a net margin of 38.86% compared to Yuanbao's net margin of 29.67%. Slide Insurance's return on equity of 48.38% beat Yuanbao's return on equity. Company Net Margins Return on Equity Return on Assets Slide Insurance 38.86% 48.38% 17.38% Yuanbao 29.67% 44.37% 30.82%

Does the media favor SLDE or YB?

In the previous week, Slide Insurance had 6 more articles in the media than Yuanbao. MarketBeat recorded 14 mentions for Slide Insurance and 8 mentions for Yuanbao. Yuanbao's average media sentiment score of 1.02 beat Slide Insurance's score of 0.19 indicating that Yuanbao is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Slide Insurance 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Yuanbao 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Yuanbao (YB) Competitors

$15.63 0.00 (0.00%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$15.85 +0.22 (+1.41%)

As of 06/12/2026 04:42 PM Eastern

Compare

YB vs. SPNT, CLOV, FIHL, PLGO, and SLDE

Should you buy Yuanbao stock or one of its competitors? MarketBeat compares Yuanbao with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Yuanbao include SiriusPoint (SPNT), Clover Health Investments (CLOV), Fidelis Insurance (FIHL), Fidelis Insurance (PLGO), and Slide Insurance (SLDE). These companies are all part of the "insurance" industry.

How does Yuanbao compare to SiriusPoint?

Yuanbao (NASDAQ:YB) and SiriusPoint (NYSE:SPNT) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Yuanbao has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market. Comparatively, SiriusPoint has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

In the previous week, Yuanbao had 8 more articles in the media than SiriusPoint. MarketBeat recorded 8 mentions for Yuanbao and 0 mentions for SiriusPoint. Yuanbao's average media sentiment score of 1.02 beat SiriusPoint's score of 0.00 indicating that Yuanbao is being referred to more favorably in the media.

Company	Overall Sentiment
Yuanbao	Positive
SiriusPoint	Neutral

52.8% of SiriusPoint shares are owned by institutional investors. 12.2% of SiriusPoint shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Yuanbao has a net margin of 29.67% compared to SiriusPoint's net margin of 15.38%. Yuanbao's return on equity of 44.37% beat SiriusPoint's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Yuanbao	29.67%	44.37%	30.82%
SiriusPoint	15.38%	16.92%	2.88%

Yuanbao currently has a consensus target price of $21.80, indicating a potential upside of 39.48%. SiriusPoint has a consensus target price of $28.00, indicating a potential upside of 19.53%. Given Yuanbao's higher possible upside, equities analysts clearly believe Yuanbao is more favorable than SiriusPoint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yuanbao	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
SiriusPoint	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

SiriusPoint has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than SiriusPoint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yuanbao	$625.35M	1.13	$181.88M	$4.14	3.78
SiriusPoint	$3.21B	0.86	$459.60M	$4.02	5.83

Summary

Yuanbao and SiriusPoint tied by winning 8 of the 16 factors compared between the two stocks.

How does Yuanbao compare to Clover Health Investments?

Clover Health Investments (NASDAQ:CLOV) and Yuanbao (NASDAQ:YB) are both insurance companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

Yuanbao has a net margin of 29.67% compared to Clover Health Investments' net margin of -2.58%. Yuanbao's return on equity of 44.37% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-2.58%	-16.52%	-9.28%
Yuanbao	29.67%	44.37%	30.82%

Clover Health Investments has a beta of 2.54, meaning that its share price is 154% more volatile than the broader market. Comparatively, Yuanbao has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market.

19.8% of Clover Health Investments shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Yuanbao had 1 more articles in the media than Clover Health Investments. MarketBeat recorded 8 mentions for Yuanbao and 7 mentions for Clover Health Investments. Yuanbao's average media sentiment score of 1.02 beat Clover Health Investments' score of 0.52 indicating that Yuanbao is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clover Health Investments	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Yuanbao	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Clover Health Investments presently has a consensus target price of $3.82, suggesting a potential downside of 19.31%. Yuanbao has a consensus target price of $21.80, suggesting a potential upside of 39.48%. Given Yuanbao's higher probable upside, analysts clearly believe Yuanbao is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Yuanbao	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Yuanbao has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Yuanbao, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$1.92B	1.29	-$85.55M	-$0.12	N/A
Yuanbao	$625.35M	1.13	$181.88M	$4.14	3.78

Summary

Yuanbao beats Clover Health Investments on 9 of the 15 factors compared between the two stocks.

How does Yuanbao compare to Fidelis Insurance?

Yuanbao (NASDAQ:YB) and Fidelis Insurance (NYSE:FIHL) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Yuanbao has a net margin of 29.67% compared to Fidelis Insurance's net margin of 9.02%. Yuanbao's return on equity of 44.37% beat Fidelis Insurance's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Yuanbao	29.67%	44.37%	30.82%
Fidelis Insurance	9.02%	8.62%	1.62%

Yuanbao currently has a consensus price target of $21.80, indicating a potential upside of 39.48%. Fidelis Insurance has a consensus price target of $21.92, indicating a potential downside of 7.33%. Given Yuanbao's higher probable upside, equities research analysts plainly believe Yuanbao is more favorable than Fidelis Insurance.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Yuanbao	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Fidelis Insurance	2 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

In the previous week, Yuanbao had 7 more articles in the media than Fidelis Insurance. MarketBeat recorded 8 mentions for Yuanbao and 1 mentions for Fidelis Insurance. Yuanbao's average media sentiment score of 1.02 beat Fidelis Insurance's score of -0.85 indicating that Yuanbao is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Yuanbao	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fidelis Insurance	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Negative

82.0% of Fidelis Insurance shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Yuanbao has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market. Comparatively, Fidelis Insurance has a beta of 0.36, suggesting that its stock price is 64% less volatile than the broader market.

Fidelis Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yuanbao	$625.35M	1.13	$181.88M	$4.14	3.78
Fidelis Insurance	$2.17B	1.05	$225.50M	$2.21	10.70

Summary

Yuanbao beats Fidelis Insurance on 9 of the 15 factors compared between the two stocks.

How does Yuanbao compare to Fidelis Insurance?

Fidelis Insurance (NYSE:PLGO) and Yuanbao (NASDAQ:YB) are both insurance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

Fidelis Insurance has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market. Comparatively, Yuanbao has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market.

In the previous week, Yuanbao had 7 more articles in the media than Fidelis Insurance. MarketBeat recorded 8 mentions for Yuanbao and 1 mentions for Fidelis Insurance. Yuanbao's average media sentiment score of 1.02 beat Fidelis Insurance's score of 0.75 indicating that Yuanbao is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fidelis Insurance	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Yuanbao	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fidelis Insurance currently has a consensus price target of $24.33, indicating a potential upside of 2.76%. Yuanbao has a consensus price target of $21.80, indicating a potential upside of 39.48%. Given Yuanbao's higher probable upside, analysts clearly believe Yuanbao is more favorable than Fidelis Insurance.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fidelis Insurance	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Yuanbao	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

82.0% of Fidelis Insurance shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fidelis Insurance	$2.50B	0.82	$225.50M	$3.74	6.33
Yuanbao	$625.35M	1.13	$181.88M	$4.14	3.78

Yuanbao has a net margin of 29.67% compared to Fidelis Insurance's net margin of 15.33%. Yuanbao's return on equity of 44.37% beat Fidelis Insurance's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fidelis Insurance	15.33%	14.44%	2.63%
Yuanbao	29.67%	44.37%	30.82%

Summary

Yuanbao beats Fidelis Insurance on 9 of the 16 factors compared between the two stocks.

How does Yuanbao compare to Slide Insurance?

Slide Insurance (NASDAQ:SLDE) and Yuanbao (NASDAQ:YB) are both small-cap insurance companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Slide Insurance has a net margin of 38.86% compared to Yuanbao's net margin of 29.67%. Slide Insurance's return on equity of 48.38% beat Yuanbao's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Slide Insurance	38.86%	48.38%	17.38%
Yuanbao	29.67%	44.37%	30.82%

Slide Insurance has higher revenue and earnings than Yuanbao. Yuanbao is trading at a lower price-to-earnings ratio than Slide Insurance, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Slide Insurance	$1.16B	1.66	$443.96M	$3.60	4.64
Yuanbao	$625.35M	1.13	$181.88M	$4.14	3.78

In the previous week, Slide Insurance had 6 more articles in the media than Yuanbao. MarketBeat recorded 14 mentions for Slide Insurance and 8 mentions for Yuanbao. Yuanbao's average media sentiment score of 1.02 beat Slide Insurance's score of 0.19 indicating that Yuanbao is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Slide Insurance	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Yuanbao	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Slide Insurance presently has a consensus price target of $24.80, indicating a potential upside of 48.50%. Yuanbao has a consensus price target of $21.80, indicating a potential upside of 39.48%. Given Slide Insurance's stronger consensus rating and higher possible upside, research analysts clearly believe Slide Insurance is more favorable than Yuanbao.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Slide Insurance	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.89
Yuanbao	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Slide Insurance beats Yuanbao on 11 of the 14 factors compared between the two stocks.

Get Yuanbao News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding YB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

YB vs. The Competition

Export

Metric	Yuanbao	INS Industry	Finance Sector	NASDAQ Exchange
Market Cap	$704.60M	$20.98B	$13.84B	$12.05B
Dividend Yield	N/A	3.21%	5.75%	5.66%
P/E Ratio	3.78	10.43	20.17	24.42
Price / Sales	1.13	1.66	140.43	110.47
Price / Cash	2.45	13.04	19.50	37.92
Price / Book	1.51	2.63	2.24	6.82
Net Income	$181.88M	$1.89B	$1.14B	$337.56M
7 Day Performance	5.25%	3.56%	1.33%	1.17%
1 Month Performance	9.92%	1.15%	2.22%	3.16%
1 Year Performance	-12.92%	2.96%	12.62%	30.58%

Yuanbao Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
YB Yuanbao	4.127 of 5 stars	$15.63 flat	$21.80 +39.5%	-12.9%	$704.60M	$625.35M	3.78	497	Positive News Dividend Announcement Short Interest Decrease Gap Up
SPNT SiriusPoint	2.8574 of 5 stars	$21.71 +3.2%	$28.00 +29.0%	+21.0%	$2.47B	$3.21B	5.40	1,099
CLOV Clover Health Investments	1.4535 of 5 stars	$3.83 -4.0%	$3.23 -15.6%	+64.2%	$2.10B	$1.92B	N/A	680
FIHL Fidelis Insurance	1.9502 of 5 stars	$21.41 +1.4%	$21.92 +2.4%	+45.7%	$2.07B	$2.17B	9.69	77
PLGO Fidelis Insurance	3.9503 of 5 stars	$21.76 +1.6%	$24.33 +11.8%	N/A	$1.85B	$2.50B	5.82	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:YB) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Yuanbao (YB) Competitors

YB vs. SPNT, CLOV, FIHL, PLGO, and SLDE

How does Yuanbao compare to SiriusPoint?

Summary

How does Yuanbao compare to Clover Health Investments?

Summary

How does Yuanbao compare to Fidelis Insurance?

Summary

How does Yuanbao compare to Fidelis Insurance?

Summary

How does Yuanbao compare to Slide Insurance?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

YB vs. The Competition

Yuanbao Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Yuanbao (YB) Competitors

YB vs. SPNT, CLOV, FIHL, PLGO, and SLDE

How does Yuanbao compare to SiriusPoint?

Which has more volatility and risk, YB or SPNT?

Does the media refer more to YB or SPNT?

Do institutionals & insiders believe in YB or SPNT?

Is YB or SPNT more profitable?

Do analysts recommend YB or SPNT?

Which has preferable valuation and earnings, YB or SPNT?

Summary

How does Yuanbao compare to Clover Health Investments?

Is CLOV or YB more profitable?

Which has more volatility & risk, CLOV or YB?

Do institutionals & insiders have more ownership in CLOV or YB?

Does the media prefer CLOV or YB?

Do analysts rate CLOV or YB?

Which has higher valuation & earnings, CLOV or YB?

Summary

How does Yuanbao compare to Fidelis Insurance?

Is YB or FIHL more profitable?

Do analysts prefer YB or FIHL?

Does the media favor YB or FIHL?

Do insiders and institutionals believe in YB or FIHL?

Which has more volatility & risk, YB or FIHL?

Which has stronger valuation and earnings, YB or FIHL?

Summary

How does Yuanbao compare to Fidelis Insurance?

Which has more risk and volatility, PLGO or YB?

Does the media prefer PLGO or YB?

Do analysts prefer PLGO or YB?

Do institutionals & insiders hold more shares of PLGO or YB?

Which has higher valuation & earnings, PLGO or YB?

Is PLGO or YB more profitable?

Summary

How does Yuanbao compare to Slide Insurance?

Is SLDE or YB more profitable?

Which has preferable earnings & valuation, SLDE or YB?

Does the media favor SLDE or YB?

Do analysts recommend SLDE or YB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

YB vs. The Competition

Yuanbao Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools